Advances and Challenges in Nasal Formulation Developments, 3rd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 1691
Special Issue Editor
Interests: nasal formulation; nasal drug delivery; mucosal absorption; CNS drug delivery; brain drug targeting; neuroinflammation; neuropathic pain; neurodegenerative diseases; sleep cycle; chronopharmacology; circadian rhythm
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Intranasal administration has the potential to target various tissues (e.g., brain targeting, lymphatic delivery, mucosal vaccination, and transmucosal absorption). The development of nasal formulations is difficult due to factors such as their retention time in the nasal cavity, dose restrictions, the difference between animal species, and individual variations in nasal drug absorption. This Special Issue will address the advances being made in various forms of nasal formulations, including in vivo and in vitro evaluations of the permeation and disposition of drugs, drug dissolution from formulations, and the development of novel dosage forms and excipients for nasal applications. Additionally, it will include studies on drug targeting from the nose to brain/lymphatic tissue, nasal vaccination, and mucosal absorption. Original research papers and review articles are welcome.
Dr. Daisuke Inoue
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nasal formulations
- intranasal dissolution and permeation
- mucosal absorption
- excipients for nasal formulations
- in vitro dissolution system
- in vivo nasal dissolution and absorption
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
